Norway· NO-ID_0A73AE2E-B6FA-49AC-A65D-13E63407F658
Peritol
A cyproheptadine product containing cyproheptadine hydrochloride 1.5-hydrate, registered in Norway by Infectopharm Arzneimittel und Consilium. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cyproheptadine is registered in 10 of 19 countries.
Countries holding a registration under ATC R06AX02 (cyproheptadine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Cyproheptadine · ATC R06AX02
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Cyproheptadine Hydrochloride 1.5-Hydrate
- Manufacturer
- Infectopharm Arzneimittel und Consilium
- Country
- Norway (NO)
- ATC code
- R06AX02
- ATC class
- Cyproheptadine
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_0A73AE2E-B6FA-49AC-A65D-13E63407F658
- no_varenummer352014100
- gtin4150087062487
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
327 interactions on record for cyproheptadine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cyproheptadine · interactions on record
327 records
- 9 severe
- 316 moderate
- 2 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cyproheptadine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCyproheptadine HydrochlorideREMEDYREPACK INC.
- CzechiaPERITOLEgis Pharmaceuticals PLC, Budapešť
- United KingdomCyproheptadine 4mg tabletsSpecial Order
- CanadaJAMP-CYPROHEPTADINEJAMP PHARMA CORPORATION
- SpainPERIACTIN 4 MG COMPRIMIDOSAlfasigma Espana S.L.
- FrancePERIACTINE 4 mg, compriméTEOFARMA
- PolandPeritolEgis Pharmaceuticals PLC
- GermanyPeritolAbanta Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Czechia · Peritol
- Germany · Peritol
- Spain · Periactin
- France · Periactine
- Hungary · Peritol
- Italy · Periactin
- Poland · Peritol
- Portugal · Viternum
- Slovakia · Peritol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbc87c68-d471-4904-896b-7eb9f3d4f89f GET /v1/drugs/dbc87c68-d471-4904-896b-7eb9f3d4f89f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Cyproheptadin",
"merkevare_id": "ID_0A73AE2E-B6FA-49AC-A65D-13E63407F658",
"name_form_strength": "Peritol tab 4 mg",
"prescription_group": "C"
}See everything about cyproheptadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.